Quest Diagnostics Incorporated

Quest Diagnostics Misses on Revenue, Stock Down 2.68%

Quest Diagnostics reported earnings that exceeded expectations on a per-share basis, but the lack of revenue data and absence of forward guidance may have contributed to the stock's decline. Investors reacted negatively, leading to a 2.68% drop in stock price. The cautious tone from management suggests a focus on stability rather than aggressive growth strategies in the near term.